{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:04:30Z","timestamp":1791345870024,"version":"4.3.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","brainanddevelopment.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.braindev.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:43:10Z","timestamp":1725968590000},"page":"383-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis with super-refractory status epilepticus"],"prefix":"10.1016","volume":"46","author":[{"given":"Yayoi","family":"Shide-Moriguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2024.09.001_bb0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody\u2013positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.braindev.2024.09.001_bb0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pediatrneurol.2023.12.018","article-title":"Encephalitis is an important phenotype of myelin oligodendrocyte glycoprotein antibody-associated diseases: a single-center cohort study","volume":"152","author":"Ren","year":"2024","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.09.001_bb0015","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/dmcn.15174","article-title":"Clinico-radiological characteristics of anti-myelin oligodendrocyte glycoprotein antibody-associated autoimmune encephalitis in children","volume":"64","author":"Han","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2024.09.001_bb0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2024.09.001_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.seizure.2022.04.001","article-title":"Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: a case report and literature review","volume":"98","author":"Tokumoto","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.09.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102011","article-title":"Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: two paradigmatic cases and a review of the literature","volume":"41","author":"Foiadelli","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.braindev.2024.09.001_bb0035","article-title":"The clinical features of FLAIR-hyperintense lesions in anti-MOG antibody associated cerebral cortical encephalitis with seizures: case reports and literature review","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.braindev.2024.09.001_bb0040","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1111\/epi.17424","article-title":"Acute symptomatic seizures secondary to myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"63","author":"Montalvo","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.09.001_bb0045","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamaneurol.2023.2407","article-title":"Outcomes and treatment approaches for super-refractory status epilepticus: a systematic review and meta-analysis","volume":"80","author":"Cornwall","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.braindev.2024.09.001_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/1535759721999670","article-title":"Treatment of super-refractory status epilepticus: a review","volume":"21","author":"Ochoa","year":"2021","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.braindev.2024.09.001_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.seizure.2024.01.013","article-title":"Ketamine in the treatment of refractory and super-refractory status epilepticus: experience from two centres","volume":"117","author":"Garc\u00eda-Ruiz","year":"2024","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.09.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.122950","article-title":"Efficacy and safety of ketamine for pediatric and adolescent super-refractory status epilepticus and the effect of cerebral inflammatory conditions","volume":"459","author":"Kuki","year":"2024","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2024.09.001_bb0065","doi-asserted-by":"crossref","first-page":"e1227","DOI":"10.1212\/WNL.0000000000200889","article-title":"Ketamine for management of neonatal and pediatric refractory status epilepticus","volume":"99","author":"Jacobwitz","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.09.001_bb0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/epi.17933","article-title":"Second-line immunotherapy in new onset refractory status epilepticus","volume":"65","author":"Hanin","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.09.001_bb0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/acn3.51308","article-title":"Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome","volume":"8","author":"Horino","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.braindev.2024.09.001_bb0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/acn3.51755","article-title":"Drug-resistant seizures associated with hyperinflammatory monocytes in FIRES","volume":"10","author":"Howe","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.braindev.2024.09.001_bb0085","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200153","article-title":"Intrathecal dexamethasone in febrile infection-related epilepsy syndrome: a case report","volume":"13","author":"Mehta","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.braindev.2024.09.001_bb0090","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jnnp-2014-309388","article-title":"Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus","volume":"86","author":"Sakuma","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2024.09.001_bb0095","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2018-317969","article-title":"CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications","volume":"89","author":"Kaneko","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2024.09.001_bb0100","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/brain\/awaa102","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study","volume":"143","author":"Takai","year":"2020","journal-title":"Brain"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T12:28:14Z","timestamp":1730464094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760424001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0387760424001268"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2024.09.001","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis with super-refractory status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}]}}